Live Ventures vs Savers Value Village
LIVE and SVV side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LIVE and SVV compare
Savers Value Village is the larger company, worth 66 times as much as Live Ventures ($1.5B against $23.0M).
Savers Value Village grew revenue faster over the last twelve months (10.1% versus −2.2% for Live Ventures).
Savers Value Village keeps more of each dollar of sales as profit, with a net margin of 3.5% compared with −0.59% at Live Ventures.
Live Ventures scores higher on the StockData Score (9 against 7 for Savers Value Village), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LIVE | SVV |
|---|---|---|
| Size and price | ||
| Market cap | $23.0M | $1.5B |
| Share price | $7.50 | $9.91 |
| Change, 1 year | −40.5% | 20.9% |
| Change, 5 years | −77.9% | – |
| Beta (5Y) | 0.30 | 0.83 |
| Employees | 1,744 | 24K |
| StockData Score | ||
| Total score | 9 (better) | 7 |
| Valuation score | 4 (better) | 3 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 | 2 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 24.8× |
| P/S | 0.1× (better) | 0.9× |
| P/B | 0.3× (better) | 3.2× |
| EV/EBITDA | 0.5× (better) | 8.9× |
| P/FCF | 1.7× (better) | 13.0× |
| FCF yield | 60.5% (better) | 7.7% |
| Fair value | $60.59 | $11.37 |
| Margin of safety | 87.6% (better) | 12.8% |
| Growth | ||
| Revenue growth (TTM) | −2.2% | 10.1% (better) |
| Revenue growth, 5Y average | 18.3% | – |
| Net income growth (TTM) | −237% | – |
| EPS growth, 5Y average | 9.8% | – |
| Profitability | ||
| Gross margin | 33.1% | 56.0% (better) |
| Operating margin | 2.4% | 8.1% (better) |
| Net margin | −0.59% | 3.5% (better) |
| FCF margin | 3.2% | 6.6% (better) |
| Return on equity | −2.8% | 14.1% (better) |
| Return on invested capital | 9.9% (better) | 9.0% |
| Financial health | ||
| Debt / equity | – | 1.41 |
| Net debt / EBITDA | – | 2.53 |
| Interest coverage | 0.7× | – |
| Current ratio | 1.35 (better) | 0.67 |
| Altman Z-score | 1.50 (better) | 1.41 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | 2.6% (better) |
| Shareholder yield | 0.00% | 2.6% (better) |
| Ownership | ||
| Held by institutions | 7.1% | 107% |
| Held by insiders | – | 76.8% |
| Insider net buying, 12 months | $2.5K (better) | −$480M |
| Short interest, % of float | – | 25.4% |
Go deeper
- LIVE stock overview
- LIVE income statement
- LIVE valuation and score
- SVV stock overview
- SVV income statement
- SVV valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.